Granules Pharmaceuticals successfully completes USFDA post marketing adverse drug experience inspection with zero observations
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
The product basket increased to 1800 medicines and 285 Surgical Equipment
Subscribe To Our Newsletter & Stay Updated